Chapter/Section Purchase

1 Pet Meds and Supplements Market Overview
1.1 Product Overview and Scope of Pet Meds and Supplements
1.2 Pet Meds and Supplements Segment by Type
1.2.1 Global Pet Meds and Supplements Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 External Use
1.2.3 Oral Use
1.3 Pet Meds and Supplements Segment by Application
1.3.1 Global Pet Meds and Supplements Sales Comparison by Application: (2022-2028)
1.3.2 Dogs
1.3.3 Cats
1.3.4 Rabbit
1.3.5 Bird
1.3.6 Other
1.4 Global Pet Meds and Supplements Market Size Estimates and Forecasts
1.4.1 Global Pet Meds and Supplements Revenue 2017-2028
1.4.2 Global Pet Meds and Supplements Sales 2017-2028
1.4.3 Pet Meds and Supplements Market Size by Region: 2017 Versus 2021 Versus 2028
2 Pet Meds and Supplements Market Competition by Manufacturers
2.1 Global Pet Meds and Supplements Sales Market Share by Manufacturers (2017-2022)
2.2 Global Pet Meds and Supplements Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Pet Meds and Supplements Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Pet Meds and Supplements Manufacturing Sites, Area Served, Product Type
2.5 Pet Meds and Supplements Market Competitive Situation and Trends
2.5.1 Pet Meds and Supplements Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pet Meds and Supplements Players Market Share by Revenue
2.5.3 Global Pet Meds and Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Meds and Supplements Retrospective Market Scenario by Region
3.1 Global Pet Meds and Supplements Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Pet Meds and Supplements Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Pet Meds and Supplements Market Facts & Figures by Country
3.3.1 North America Pet Meds and Supplements Sales by Country
3.3.2 North America Pet Meds and Supplements Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Pet Meds and Supplements Market Facts & Figures by Country
3.4.1 Europe Pet Meds and Supplements Sales by Country
3.4.2 Europe Pet Meds and Supplements Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pet Meds and Supplements Market Facts & Figures by Region
3.5.1 Asia Pacific Pet Meds and Supplements Sales by Region
3.5.2 Asia Pacific Pet Meds and Supplements Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Pet Meds and Supplements Market Facts & Figures by Country
3.6.1 Latin America Pet Meds and Supplements Sales by Country
3.6.2 Latin America Pet Meds and Supplements Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Pet Meds and Supplements Market Facts & Figures by Country
3.7.1 Middle East and Africa Pet Meds and Supplements Sales by Country
3.7.2 Middle East and Africa Pet Meds and Supplements Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Pet Meds and Supplements Historic Market Analysis by Type
4.1 Global Pet Meds and Supplements Sales Market Share by Type (2017-2022)
4.2 Global Pet Meds and Supplements Revenue Market Share by Type (2017-2022)
4.3 Global Pet Meds and Supplements Price by Type (2017-2022)
5 Global Pet Meds and Supplements Historic Market Analysis by Application
5.1 Global Pet Meds and Supplements Sales Market Share by Application (2017-2022)
5.2 Global Pet Meds and Supplements Revenue Market Share by Application (2017-2022)
5.3 Global Pet Meds and Supplements Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Boehringer Ingelheim Pet Meds and Supplements Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Ceva Sante Animale
6.2.1 Ceva Sante Animale Corporation Information
6.2.2 Ceva Sante Animale Description and Business Overview
6.2.3 Ceva Sante Animale Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Ceva Sante Animale Pet Meds and Supplements Product Portfolio
6.2.5 Ceva Sante Animale Recent Developments/Updates
6.3 Bimeda Animal Health
6.3.1 Bimeda Animal Health Corporation Information
6.3.2 Bimeda Animal Health Description and Business Overview
6.3.3 Bimeda Animal Health Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Bimeda Animal Health Pet Meds and Supplements Product Portfolio
6.3.5 Bimeda Animal Health Recent Developments/Updates
6.4 Dechra Pharmaceuticals
6.4.1 Dechra Pharmaceuticals Corporation Information
6.4.2 Dechra Pharmaceuticals Description and Business Overview
6.4.3 Dechra Pharmaceuticals Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Dechra Pharmaceuticals Pet Meds and Supplements Product Portfolio
6.4.5 Dechra Pharmaceuticals Recent Developments/Updates
6.5 Zoetis
6.5.1 Zoetis Corporation Information
6.5.2 Zoetis Description and Business Overview
6.5.3 Zoetis Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Zoetis Pet Meds and Supplements Product Portfolio
6.5.5 Zoetis Recent Developments/Updates
6.6 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Merck Pet Meds and Supplements Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Elanco
6.6.1 Elanco Corporation Information
6.6.2 Elanco Description and Business Overview
6.6.3 Elanco Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Elanco Pet Meds and Supplements Product Portfolio
6.7.5 Elanco Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Corporation Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Bayer Pet Meds and Supplements Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 Boehringer
6.9.1 Boehringer Corporation Information
6.9.2 Boehringer Description and Business Overview
6.9.3 Boehringer Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Boehringer Pet Meds and Supplements Product Portfolio
6.9.5 Boehringer Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Novartis Pet Meds and Supplements Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Virbac
6.11.1 Virbac Corporation Information
6.11.2 Virbac Pet Meds and Supplements Description and Business Overview
6.11.3 Virbac Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Virbac Pet Meds and Supplements Product Portfolio
6.11.5 Virbac Recent Developments/Updates
6.12 Ceva
6.12.1 Ceva Corporation Information
6.12.2 Ceva Pet Meds and Supplements Description and Business Overview
6.12.3 Ceva Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Ceva Pet Meds and Supplements Product Portfolio
6.12.5 Ceva Recent Developments/Updates
6.13 Vetoquinol
6.13.1 Vetoquinol Corporation Information
6.13.2 Vetoquinol Pet Meds and Supplements Description and Business Overview
6.13.3 Vetoquinol Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Vetoquinol Pet Meds and Supplements Product Portfolio
6.13.5 Vetoquinol Recent Developments/Updates
6.14 Nexvet
6.14.1 Nexvet Corporation Information
6.14.2 Nexvet Pet Meds and Supplements Description and Business Overview
6.14.3 Nexvet Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Nexvet Pet Meds and Supplements Product Portfolio
6.14.5 Nexvet Recent Developments/Updates
6.15 Aratana Therapeutics
6.15.1 Aratana Therapeutics Corporation Information
6.15.2 Aratana Therapeutics Pet Meds and Supplements Description and Business Overview
6.15.3 Aratana Therapeutics Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Aratana Therapeutics Pet Meds and Supplements Product Portfolio
6.15.5 Aratana Therapeutics Recent Developments/Updates
6.16 Kindred Biosciences
6.16.1 Kindred Biosciences Corporation Information
6.16.2 Kindred Biosciences Pet Meds and Supplements Description and Business Overview
6.16.3 Kindred Biosciences Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Kindred Biosciences Pet Meds and Supplements Product Portfolio
6.16.5 Kindred Biosciences Recent Developments/Updates
6.17 Ambrx
6.17.1 Ambrx Corporation Information
6.17.2 Ambrx Pet Meds and Supplements Description and Business Overview
6.17.3 Ambrx Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Ambrx Pet Meds and Supplements Product Portfolio
6.17.5 Ambrx Recent Developments/Updates
6.18 Entest Biomedical
6.18.1 Entest Biomedical Corporation Information
6.18.2 Entest Biomedical Pet Meds and Supplements Description and Business Overview
6.18.3 Entest Biomedical Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Entest Biomedical Pet Meds and Supplements Product Portfolio
6.18.5 Entest Biomedical Recent Developments/Updates
6.19 Taconic Biosciences
6.19.1 Taconic Biosciences Corporation Information
6.19.2 Taconic Biosciences Pet Meds and Supplements Description and Business Overview
6.19.3 Taconic Biosciences Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Taconic Biosciences Pet Meds and Supplements Product Portfolio
6.19.5 Taconic Biosciences Recent Developments/Updates
6.20 Dechra Veterinary Products
6.20.1 Dechra Veterinary Products Corporation Information
6.20.2 Dechra Veterinary Products Pet Meds and Supplements Description and Business Overview
6.20.3 Dechra Veterinary Products Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Dechra Veterinary Products Pet Meds and Supplements Product Portfolio
6.20.5 Dechra Veterinary Products Recent Developments/Updates
6.21 Ouro Fino Saude
6.21.1 Ouro Fino Saude Corporation Information
6.21.2 Ouro Fino Saude Pet Meds and Supplements Description and Business Overview
6.21.3 Ouro Fino Saude Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Ouro Fino Saude Pet Meds and Supplements Product Portfolio
6.21.5 Ouro Fino Saude Recent Developments/Updates
6.22 Norbrook
6.22.1 Norbrook Corporation Information
6.22.2 Norbrook Pet Meds and Supplements Description and Business Overview
6.22.3 Norbrook Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Norbrook Pet Meds and Supplements Product Portfolio
6.22.5 Norbrook Recent Developments/Updates
6.23 Frontline
6.23.1 Frontline Corporation Information
6.23.2 Frontline Pet Meds and Supplements Description and Business Overview
6.23.3 Frontline Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Frontline Pet Meds and Supplements Product Portfolio
6.23.5 Frontline Recent Developments/Updates
6.24 Zesty Paws
6.24.1 Zesty Paws Corporation Information
6.24.2 Zesty Paws Pet Meds and Supplements Description and Business Overview
6.24.3 Zesty Paws Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.24.4 Zesty Paws Pet Meds and Supplements Product Portfolio
6.24.5 Zesty Paws Recent Developments/Updates
7 Pet Meds and Supplements Manufacturing Cost Analysis
7.1 Pet Meds and Supplements Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pet Meds and Supplements
7.4 Pet Meds and Supplements Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pet Meds and Supplements Distributors List
8.3 Pet Meds and Supplements Customers
9 Pet Meds and Supplements Market Dynamics
9.1 Pet Meds and Supplements Industry Trends
9.2 Pet Meds and Supplements Market Drivers
9.3 Pet Meds and Supplements Market Challenges
9.4 Pet Meds and Supplements Market Restraints
10 Global Market Forecast
10.1 Pet Meds and Supplements Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pet Meds and Supplements by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Pet Meds and Supplements by Type (2023-2028)
10.2 Pet Meds and Supplements Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pet Meds and Supplements by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Pet Meds and Supplements by Application (2023-2028)
10.3 Pet Meds and Supplements Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pet Meds and Supplements by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Pet Meds and Supplements by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer